Treatment angiotensin converting enzyme inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy29

Kidney Muscle, Smooth, Vascular Myocardium Cells, Cultured Aorta Kidney Glomerulus Endothelium, Vascular Sympathetic Nervous System Heart Adrenal Glands Aorta, Thoracic Mesenteric Arteries Kidney Cortex Arteries Subfornical Organ Kidney Tubules, Proximal Juxtaglomerular Apparatus Blood Vessels Arterioles Heart Ventricles Renal Artery Pressoreceptors Cardiovascular System Zona Glomerulosa Forearm Glomerular Mesangium Kidney Tubules Adrenal Cortex Kidney Medulla

Organisms11

Rats, Inbred SHR Rats, Sprague-Dawley Rats, Inbred WKY Rats, Wistar Rats, Inbred Strains Dogs Rabbits Mice, Inbred C57BL Mice, Knockout Digitalis Cattle

Diseases32

Hypertension Heart Failure Hypertension, Renal Proteinuria Angioedema Hypertension, Renovascular Cardiomegaly Diabetic Nephropathies Hyperkalemia Kidney Diseases Disease Models, Animal Fibrosis Albuminuria Hypertrophy Hypertrophy, Left Ventricular Kidney Failure, Chronic Myocardial Infarction Cardiac Output, Low Ventricular Remodeling Body Weight Chronic Disease Hypotension Ventricular Dysfunction, Left Cough Cardiovascular Diseases Renal Artery Obstruction Oligohydramnios Disease Progression Diabetes Mellitus, Type 2 Hypertension, Malignant Renal Insufficiency Glomerulosclerosis, Focal Segmental

Chemicals and Drugs121

Angiotensin II Angiotensin-Converting Enzyme Inhibitors Receptor, Angiotensin, Type 1 Receptors, Angiotensin Receptor, Angiotensin, Type 2 Angiotensin I Angiotensin Receptor Antagonists Angiotensin II Type 1 Receptor Blockers Enalapril Angiotensin III Tetrazoles Losartan Captopril Peptidyl-Dipeptidase A Antihypertensive Agents Renin Angiotensin II Type 2 Receptor Blockers Lisinopril Angiotensins Enalaprilat Biphenyl Compounds Saralasin Teprotide Perindopril Imidazoles Ramipril Benzimidazoles Cilazapril Enzyme Inhibitors 1-Sarcosine-8-Isoleucine Angiotensin II Thiazepines Aldosterone Bradykinin Vasoconstrictor Agents Diuretics Angiotensinogen Tetrahydroisoquinolines Adrenergic beta-Antagonists Imidazolidines 3-Mercaptopropionic Acid Kinins Hydralazine Valine Pyridines Fosinopril Receptors, Bradykinin Angiotensin Amide Calcium Channel Blockers Norepinephrine Benzoates Oligopeptides Mineralocorticoid Receptor Antagonists RNA, Messenger Hydrochlorothiazide Spironolactone Chymases Amlodipine Receptor, Bradykinin B2 Indoles Cardiovascular Agents Sodium Chloride Symporter Inhibitors Benzazepines Sodium Fumarates Proline Nitric Oxide Dipeptides Endothelin-1 Creatinine Furosemide Sodium, Dietary Endothelins Neprilysin Atrial Natriuretic Factor Protease Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors NG-Nitroarginine Methyl Ester NADPH Oxidase Isoquinolines Vasodilator Agents Vasopressins Arginine Vasopressin Phenylephrine Sodium Chloride, Dietary Sodium Chloride Peptide Fragments Receptor, Bradykinin B1 Receptors, Endothelin Amides Nitric Oxide Synthase Aminopeptidases Glutamyl Aminopeptidase Indomethacin Desoxycorticosterone Thiorphan Mopidamol Calcium Potassium Atenolol Superoxides Bicyclo Compounds Reactive Oxygen Species Kallikreins Pyridazines Cardiotonic Agents Phenylmethylsulfonyl Fluoride Cyclooxygenase Inhibitors Acrylates Prostaglandins Protein Kinase C Aldosterone Synthase Nifedipine Collagen Cyclohexanones Doxazosin Transforming Growth Factor beta Receptor, Endothelin A Aspirin Nitroprusside Nitric Oxide Synthase Type III Electrolytes

Analytical, Diagnostic and Therapeutic Techniques and Equipment30

Blood Pressure Drug Therapy, Combination Diet, Sodium-Restricted Heart Rate Nephrectomy Glomerular Filtration Rate Disease Models, Animal Treatment Outcome Double-Blind Method Organ Size Analysis of Variance Body Weight Cross-Over Studies Perfusion Risk Factors Retrospective Studies Randomized Controlled Trials as Topic Random Allocation Injections, Intraventricular Kidney Function Tests Follow-Up Studies Prospective Studies Infusion Pumps, Implantable Immunohistochemistry Reference Values Radioimmunoassay Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Administration, Oral Stroke Volume

Psychiatry and Psychology1

Phenomena and Processes32

Renin-Angiotensin System Blood Pressure Dose-Response Relationship, Drug Renal Circulation Hemodynamics Time Factors Vasoconstriction Diet, Sodium-Restricted Heart Rate Glomerular Filtration Rate Drinking Vascular Resistance Organ Size Vasodilation Signal Transduction Natriuresis Ventricular Remodeling Drug Interactions Body Weight Oxidative Stress Systole Ventricular Function, Left Kinetics Drug Synergism Diuresis Regional Blood Flow Enzyme Activation Gene Expression Phosphorylation Gene Expression Regulation Up-Regulation Stroke Volume

Disciplines and Occupations1

Immunohistochemistry

Health Care15

Treatment Outcome Double-Blind Method Analysis of Variance Cross-Over Studies Risk Factors Retrospective Studies Randomized Controlled Trials as Topic Random Allocation Follow-Up Studies Prospective Studies Drug Utilization Review Secondary Prevention Practice Guidelines as Topic Drug Utilization Guideline Adherence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Health Care

Angiotensin II Angiotensin-Converting Enzyme Inhibitors Receptor, Angiotensin, Type 1 Receptors, Angiotensin Receptor, Angiotensin, Type 2 Angiotensin I Angiotensin Receptor Antagonists Angiotensin II Type 1 Receptor Blockers Enalapril Angiotensin III Tetrazoles Losartan Renin-Angiotensin System Captopril Peptidyl-Dipeptidase A Antihypertensive Agents Renin Angiotensin II Type 2 Receptor Blockers Blood Pressure Lisinopril Angiotensins Hypertension Enalaprilat Biphenyl Compounds Saralasin Teprotide Perindopril Imidazoles Ramipril Benzimidazoles Cilazapril Enzyme Inhibitors 1-Sarcosine-8-Isoleucine Angiotensin II Kidney Thiazepines Aldosterone Bradykinin Vasoconstrictor Agents Rats, Inbred SHR Diuretics Angiotensinogen Rats, Sprague-Dawley Tetrahydroisoquinolines Adrenergic beta-Antagonists Imidazolidines Heart Failure Rats, Inbred WKY Hypertension, Renal 3-Mercaptopropionic Acid Kinins Proteinuria Dose-Response Relationship, Drug Angioedema Drug Therapy, Combination Hydralazine Valine Pyridines Renal Circulation Fosinopril Receptors, Bradykinin Rats, Wistar Hemodynamics Muscle, Smooth, Vascular Time Factors Angiotensin Amide Hypertension, Renovascular Calcium Channel Blockers Myocardium Norepinephrine Vasoconstriction Cells, Cultured Benzoates Diet, Sodium-Restricted Oligopeptides Heart Rate Mineralocorticoid Receptor Antagonists RNA, Messenger Hydrochlorothiazide Aorta Cardiomegaly Spironolactone Diabetic Nephropathies Hyperkalemia Chymases Nephrectomy Kidney Diseases Amlodipine Receptor, Bradykinin B2 Glomerular Filtration Rate Indoles Cardiovascular Agents Rats, Inbred Strains Disease Models, Animal Drinking Fibrosis Treatment Outcome Vascular Resistance Double-Blind Method Sodium Chloride Symporter Inhibitors Dogs

No FAQ available that match "treatment angiotensin converting enzyme inhibitors"